Antibody persistence 7 years after hepatitis-A vaccine in children with human immunodeficiency virus infection

• Egile Nagusiak: José G. Vázquez-Rosales (Egilea), Alejandra P. Melgoza-Salazar (Egilea), Mariana G. Sámano-Aviña (Egilea), Victoria E. Montaño-Luna (Egilea), Ma. Rosalía Lira-Carmona (Egilea), Fortino Solórzano-Santos (Egilea)
• Formatua: Liburua
• Argitaratua: Permanyer, 2024-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: HIV-infected children have a higher risk of presenting infections, including the hepatitis A virus (HAV). The inactivated HAV vaccine is immunogenic in immunocompetent hosts; however, there are insufficient studies on the duration of seroprotection in HIV-infected children. Methods: An a...